Literature DB >> 19141260

Medical and Catheter-Based Therapies for Managing Stable Coronary Disease: Lessons From the COURAGE Trial.

Dean J Kereiakes1.   

Abstract

Medical and catheter-based therapies play complementary roles in treating patients with stable coronary atherosclerosis. The choice of therapy (or therapies) must be made for each patient based on coronary anatomic suitability and in the context of the patient's lifestyle, functional capacity, level of symptom limitation, and ability to take the prescribed treatment. Objective evidence of myocardial ischemia on nuclear myocardial scintigraphy is quantitatively correlated with the occurrence of death or myocardial infarction in late follow-up, and percutaneous coronary intervention added to optimal medical therapy is more effective than medical therapy alone in reducing ischemia. Coronary angiography and definition of the coronary anatomy should be performed in patients with stable angina pectoris to help in selecting the optimal treatment strategy.

Entities:  

Year:  2009        PMID: 19141260     DOI: 10.1007/s11936-009-0005-9

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  31 in total

Review 1.  Coronary-artery stents.

Authors:  Patrick W Serruys; Michael J B Kutryk; Andrew T L Ong
Journal:  N Engl J Med       Date:  2006-02-02       Impact factor: 91.245

2.  The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.

Authors:  William E Boden; Robert A O'rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; John A Spertus; Leslee Shaw; Bernard R Chaitman; G B John Mancini; Daniel S Berman; Gerald Gau; William S Weintraub
Journal:  Am J Cardiol       Date:  2006-11-17       Impact factor: 2.778

3.  Prevalence, awareness, treatment, and control of hypertension in the elderly: the Three City study.

Authors:  Pauline Brindel; Oliver Hanon; Jean-François Dartigues; Karen Ritchie; Jean-Marc Lacombe; Pierre Ducimetière; Annick Alpérovitch; Christophe Tzourio
Journal:  J Hypertens       Date:  2006-01       Impact factor: 4.844

4.  Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.

Authors:  Whady Hueb; Neuza Helena Lopes; Bernard J Gersh; Paulo Soares; Luiz A C Machado; Fabio B Jatene; Sergio A Oliveira; Jose A F Ramires
Journal:  Circulation       Date:  2007-03-06       Impact factor: 29.690

5.  Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry).

Authors:  Benjamin A Steinberg; P Gabriel Steg; Deepak L Bhatt; Gregg C Fonarow; Uwe Zeymer; Christopher P Cannon
Journal:  Am J Cardiol       Date:  2007-03-16       Impact factor: 2.778

6.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

7.  Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.

Authors:  Jassim Al Suwaidi; David R Holmes; Amar M Salam; Ryan Lennon; Peter B Berger
Journal:  Am Heart J       Date:  2004-05       Impact factor: 4.749

8.  A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators.

Authors:  A F Parisi; E D Folland; P Hartigan
Journal:  N Engl J Med       Date:  1992-01-02       Impact factor: 91.245

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.